Janet Cohen Sherman, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebellar Diseases | 7 | 2021 | 227 | 1.470 |
Why?
|
| Neuropsychiatry | 1 | 2023 | 76 | 0.840 |
Why?
|
| Cognition Disorders | 8 | 2021 | 3980 | 0.670 |
Why?
|
| Telemedicine | 3 | 2023 | 3109 | 0.540 |
Why?
|
| Neurology | 1 | 2023 | 786 | 0.500 |
Why?
|
| Cognition | 14 | 2023 | 7073 | 0.380 |
Why?
|
| Neuropsychological Tests | 15 | 2022 | 7140 | 0.290 |
Why?
|
| Glioma | 3 | 2019 | 3503 | 0.280 |
Why?
|
| Neuropsychology | 2 | 2021 | 110 | 0.220 |
Why?
|
| Memory, Short-Term | 2 | 2021 | 1008 | 0.210 |
Why?
|
| Obesity, Abdominal | 2 | 2016 | 375 | 0.200 |
Why?
|
| Alzheimer Disease | 3 | 2021 | 8759 | 0.180 |
Why?
|
| Cerebellum | 1 | 2007 | 1522 | 0.160 |
Why?
|
| Hospitals, General | 1 | 2023 | 809 | 0.160 |
Why?
|
| Brain Neoplasms | 3 | 2019 | 9118 | 0.160 |
Why?
|
| Executive Function | 5 | 2018 | 1401 | 0.160 |
Why?
|
| Ataxia Telangiectasia | 1 | 2019 | 107 | 0.150 |
Why?
|
| Neurosecretory Systems | 1 | 2019 | 223 | 0.140 |
Why?
|
| Affect | 4 | 2019 | 1495 | 0.140 |
Why?
|
| Semantics | 2 | 1993 | 618 | 0.140 |
Why?
|
| Mental Recall | 2 | 2018 | 1226 | 0.140 |
Why?
|
| Language | 2 | 2021 | 1557 | 0.130 |
Why?
|
| Frontotemporal Lobar Degeneration | 1 | 2017 | 102 | 0.130 |
Why?
|
| Visual Perception | 3 | 2018 | 1402 | 0.130 |
Why?
|
| Aphasia, Primary Progressive | 1 | 2017 | 84 | 0.130 |
Why?
|
| Human Growth Hormone | 2 | 2016 | 651 | 0.120 |
Why?
|
| Activities of Daily Living | 1 | 2023 | 2430 | 0.120 |
Why?
|
| Corpus Callosum | 1 | 2019 | 753 | 0.110 |
Why?
|
| Pandemics | 3 | 2023 | 8748 | 0.110 |
Why?
|
| Reference Values | 1 | 2021 | 4938 | 0.110 |
Why?
|
| Longevity | 1 | 2021 | 1077 | 0.110 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2016 | 553 | 0.110 |
Why?
|
| Neurodegenerative Diseases | 1 | 2022 | 1095 | 0.110 |
Why?
|
| Attention | 4 | 2016 | 2424 | 0.100 |
Why?
|
| Social Perception | 1 | 2016 | 434 | 0.100 |
Why?
|
| Atrophy | 1 | 2018 | 1646 | 0.100 |
Why?
|
| Memory | 3 | 2016 | 2208 | 0.100 |
Why?
|
| Testosterone | 3 | 2016 | 2491 | 0.100 |
Why?
|
| Memory Disorders | 2 | 2018 | 1200 | 0.100 |
Why?
|
| Concept Formation | 1 | 1993 | 160 | 0.100 |
Why?
|
| Radiation Injuries | 1 | 2019 | 1198 | 0.100 |
Why?
|
| Language Development | 1 | 1993 | 183 | 0.090 |
Why?
|
| Axons | 1 | 2019 | 1677 | 0.090 |
Why?
|
| Temporal Lobe | 2 | 2017 | 1726 | 0.090 |
Why?
|
| Massachusetts | 1 | 2023 | 8890 | 0.090 |
Why?
|
| Neurologic Examination | 3 | 2018 | 914 | 0.090 |
Why?
|
| Mood Disorders | 1 | 1997 | 1129 | 0.090 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 1 | 2011 | 134 | 0.090 |
Why?
|
| Aphasia, Broca | 1 | 1989 | 52 | 0.080 |
Why?
|
| Limbic Encephalitis | 1 | 2008 | 36 | 0.080 |
Why?
|
| Humans | 31 | 2023 | 768166 | 0.080 |
Why?
|
| Adiposity | 2 | 2016 | 1895 | 0.080 |
Why?
|
| Aphasia | 1 | 1989 | 193 | 0.070 |
Why?
|
| Dementia | 1 | 2022 | 2740 | 0.070 |
Why?
|
| Syndrome | 3 | 2019 | 3272 | 0.070 |
Why?
|
| Carcinoid Tumor | 1 | 2008 | 225 | 0.070 |
Why?
|
| Mental Disorders | 1 | 2007 | 6874 | 0.070 |
Why?
|
| Learning | 1 | 2016 | 1759 | 0.070 |
Why?
|
| Mediastinal Neoplasms | 1 | 2008 | 403 | 0.060 |
Why?
|
| Verbal Learning | 2 | 2018 | 465 | 0.060 |
Why?
|
| Speech Perception | 1 | 1989 | 510 | 0.060 |
Why?
|
| Multiple Sclerosis | 1 | 2019 | 3250 | 0.060 |
Why?
|
| Hypopituitarism | 1 | 2006 | 253 | 0.060 |
Why?
|
| Aged | 11 | 2022 | 171504 | 0.050 |
Why?
|
| Middle Aged | 17 | 2019 | 223492 | 0.050 |
Why?
|
| Adult | 17 | 2019 | 223646 | 0.050 |
Why?
|
| Young Adult | 7 | 2019 | 60066 | 0.050 |
Why?
|
| Reading | 1 | 1986 | 543 | 0.050 |
Why?
|
| Female | 21 | 2019 | 397192 | 0.050 |
Why?
|
| Male | 18 | 2019 | 364719 | 0.040 |
Why?
|
| Hormone Replacement Therapy | 1 | 2006 | 757 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 15948 | 0.040 |
Why?
|
| Body Composition | 3 | 2016 | 2462 | 0.040 |
Why?
|
| Androgens | 1 | 2006 | 1281 | 0.040 |
Why?
|
| Child | 3 | 2021 | 80917 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2018 | 6029 | 0.030 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 1 | 2019 | 256 | 0.030 |
Why?
|
| Quality of Life | 4 | 2019 | 13490 | 0.030 |
Why?
|
| Emotional Intelligence | 1 | 2016 | 135 | 0.030 |
Why?
|
| Cerebellar Ataxia | 1 | 2016 | 151 | 0.030 |
Why?
|
| Fatal Outcome | 2 | 2011 | 1836 | 0.030 |
Why?
|
| Brain | 4 | 2017 | 27360 | 0.030 |
Why?
|
| ROC Curve | 1 | 2022 | 3628 | 0.030 |
Why?
|
| Stroke | 1 | 2016 | 9755 | 0.030 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2019 | 558 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 20227 | 0.030 |
Why?
|
| Brain Chemistry | 1 | 2017 | 958 | 0.030 |
Why?
|
| Cerebral Infarction | 1 | 1998 | 969 | 0.030 |
Why?
|
| Cerebellar Neoplasms | 1 | 1998 | 591 | 0.030 |
Why?
|
| Autopsy | 1 | 2017 | 1011 | 0.030 |
Why?
|
| Parietal Lobe | 1 | 2018 | 866 | 0.030 |
Why?
|
| Psycholinguistics | 1 | 1993 | 81 | 0.030 |
Why?
|
| Body Weight | 1 | 2003 | 4627 | 0.030 |
Why?
|
| Child Language | 1 | 1993 | 62 | 0.030 |
Why?
|
| Empathy | 1 | 2016 | 474 | 0.020 |
Why?
|
| Weight Loss | 1 | 2003 | 2721 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2019 | 1835 | 0.020 |
Why?
|
| Cerebrovascular Disorders | 1 | 1998 | 1485 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2021 | 42669 | 0.020 |
Why?
|
| Obesity | 1 | 2013 | 13090 | 0.020 |
Why?
|
| Insulin Resistance | 2 | 2016 | 3986 | 0.020 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2011 | 85 | 0.020 |
Why?
|
| Anomia | 1 | 1989 | 13 | 0.020 |
Why?
|
| Double-Blind Method | 3 | 2016 | 12465 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2021 | 5315 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2013 | 1942 | 0.020 |
Why?
|
| Hydrocephalus | 1 | 1996 | 768 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 2744 | 0.020 |
Why?
|
| Adolescent | 5 | 2019 | 89169 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2011 | 855 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2019 | 54926 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2019 | 41754 | 0.020 |
Why?
|
| Mediastinum | 1 | 2008 | 272 | 0.020 |
Why?
|
| Adiponectin | 1 | 2013 | 1117 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2019 | 2815 | 0.020 |
Why?
|
| Body Mass Index | 2 | 2016 | 13053 | 0.020 |
Why?
|
| Motor Activity | 1 | 2016 | 2711 | 0.020 |
Why?
|
| Confusion | 1 | 2008 | 278 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2016 | 6340 | 0.020 |
Why?
|
| Cross-Sectional Studies | 3 | 2016 | 26379 | 0.020 |
Why?
|
| Estrogens | 1 | 2013 | 1536 | 0.020 |
Why?
|
| Form Perception | 1 | 1986 | 175 | 0.020 |
Why?
|
| Encephalitis | 1 | 2008 | 441 | 0.010 |
Why?
|
| Diagnosis, Differential | 2 | 2011 | 13014 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 6847 | 0.010 |
Why?
|
| Adrenal Insufficiency | 1 | 2006 | 195 | 0.010 |
Why?
|
| Brain Ischemia | 1 | 2016 | 3007 | 0.010 |
Why?
|
| Pedigree | 1 | 2011 | 4539 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 59629 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2016 | 8741 | 0.010 |
Why?
|
| Intelligence Tests | 1 | 2003 | 504 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2019 | 9015 | 0.010 |
Why?
|
| Hormones | 1 | 2006 | 866 | 0.010 |
Why?
|
| Homeostasis | 1 | 2013 | 3348 | 0.010 |
Why?
|
| Disease Progression | 1 | 2019 | 13671 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2013 | 3329 | 0.010 |
Why?
|
| Epilepsy | 1 | 1996 | 3327 | 0.010 |
Why?
|
| Time Factors | 3 | 2016 | 40218 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2017 | 6669 | 0.010 |
Why?
|
| Arousal | 1 | 2006 | 1180 | 0.010 |
Why?
|
| Reaction Time | 1 | 1986 | 2101 | 0.010 |
Why?
|
| Radiography | 1 | 2011 | 6983 | 0.010 |
Why?
|
| Hypogonadism | 1 | 2006 | 805 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 9615 | 0.010 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2003 | 707 | 0.010 |
Why?
|
| Vitamin D | 1 | 2013 | 3311 | 0.010 |
Why?
|
| Insulin | 1 | 2013 | 6607 | 0.010 |
Why?
|
| Seizures | 1 | 2011 | 2998 | 0.010 |
Why?
|
| Pituitary Diseases | 1 | 1998 | 137 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2003 | 2596 | 0.010 |
Why?
|
| HIV Infections | 1 | 2003 | 17569 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 14783 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2008 | 36743 | 0.010 |
Why?
|
| Hemosiderosis | 1 | 1996 | 66 | 0.010 |
Why?
|
| Sexual Behavior | 1 | 2006 | 2197 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2011 | 6314 | 0.010 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 1996 | 186 | 0.010 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2003 | 1903 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2011 | 5812 | 0.010 |
Why?
|
| Placebos | 1 | 1998 | 1667 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1996 | 15832 | 0.010 |
Why?
|
| Bone Density | 1 | 2006 | 3573 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2016 | 65371 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2008 | 20760 | 0.010 |
Why?
|
| Lung | 1 | 2008 | 10099 | 0.010 |
Why?
|
| Functional Laterality | 1 | 1996 | 2264 | 0.010 |
Why?
|
| Sex Factors | 1 | 2003 | 10632 | 0.010 |
Why?
|
| Brain Diseases | 1 | 1996 | 1554 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1996 | 39348 | 0.000 |
Why?
|